Thailand FDA Product Registration Cost For Medical Device

Scope and evidence must be confirmed before any paid tests or filings.

The price of registering a medical device with the Thai Food and Drug Administration (Thai FDA) is not a single tariff. Start by separating the government product-application charges from establishment costs, technical evidence, and contracted local services.

For budgeting, first fix three facts: the device’s Thai risk class (1, 2–3 or 4), import versus local manufacture, and whether an existing Thai establishment registrant will file. Figures below are in Thai baht (THB), not service quotations.

Official product-fee matrix: what the quoted figures cover

The Thai FDA publishes the following component totals for listing (Class 1), notification (Classes 2–3) and licensing (Class 4). Higher-class figures include the published expert technical-review component; whether it is actually assessed on a particular dossier must be checked.

Thai FDA route	Local manufacture: THB	Import: THB
Class 1 — listing	1,800	3,100
Classes 2–3 — notification	36,400	49,000
Class 4 — licence	53,400	74,000

Breakdown: Class 1 comprises application 500 + data check 300 (manufacture) or 600 (import) + certificate 1,000 or 2,000. Classes 2–3 comprise application 1,000 + certificate 5,000/10,000 + published expert review 30,400/38,000. Class 4 comprises application 1,000 + certificate 10,000/20,000 + published expert review 42,400/53,000 (manufacture/import respectively).

Where expert review is not assessed, arithmetic subtotals excluding it are THB 6,000/11,000 for Classes 2–3 and THB 11,000/21,000 for Class 4 (manufacture/import). These are conditional calculations, not confirmation of a cheaper route or an official all-inclusive quote. Check the current fee demand and any updated notification before payment.

Cost lines outside the product certificate

A product-fee total is not a market-entry budget. The separate lines below may be zero, already covered by another party, or substantial; do not automatically add them once per model.

Line item	Budget treatment	Verification before quoting
Establishment registration	Thai FDA shows THB 14,100 for a new manufacturing establishment and THB 16,100 for a new importing establishment.	Check whether the filing entity already holds a suitable establishment registration; this is not a per-device fee.
Optional risk-class/grouping certificate	Thai FDA’s published general-device schedule shows THB 1,500 (THB 1,000 application plus THB 500 certificate) if a formal classification/grouping certificate is requested.	Consider only when risk class or grouping is genuinely uncertain; confirm current applicability and fee before applying.
Local filing and licence-holder services	Commercially quoted: regulatory submission, representation, correspondence, ongoing support and contractual exit.	Identify the Thai applicant and precisely what the annual or project fee includes.
Evidence, testing and translation	Supplier or laboratory quotations depend on device characteristics and the missing dossier evidence.	Inventory existing reports, labels, Thai documents, manufacturing evidence and what Thai FDA accepts.
Changes, renewal and post-approval work	Reserve a separate future budget rather than hiding it in an initial filing price.	Ask who pays for variations, renewals, complaints, reporting and any required additional review.

Avoid double counting: distinguish a payment to Thai FDA, a third-party invoice and a firm’s professional fee. Obtain itemised estimates in THB and identify taxes, currency conversion and payment triggers.

Three budgeting scenarios — not three promised prices

Use these as decision models, not claims about the actual cost of any named device.

Scenario	Government-fee starting point	Missing cost decision
Class 1 imported device; licensed importer already engaged	THB 3,100 per eligible listing application in the published matrix.	Confirm grouping and importer scope; obtain translation, dossier and licence-holder quotations.
Class 2–3 import; technical assessment uncertain	THB 11,000 without the review component versus THB 49,000 with the published THB 38,000 component.	Verify risk classification, evidence sufficiency, and whether an expert assessment will be charged.
Class 4 import; new importer establishment	Product table THB 74,000 including published review; separate establishment table THB 16,100 if a new registration is necessary.	Confirm the review, actual applicant, business premises and any testing before adding these amounts.

Four avoidable budget overruns

The costliest mistake is treating a risk-class estimate or a supplier’s approval as a final Thai filing decision.

Wrong class or medical-device status: lock the intended use and claims; request a formal determination where uncertainty justifies its separate expense.
Incorrect grouping: a family, system, set and individual device need not create the same application count; secure a defensible grouping decision before multiplying fees.
Unusable or mismatched evidence: reconcile the actual product, manufacturing sites, versions, lab reports and proposed Thai claims before paying to translate or re-test.
Unclear holder contract: specify renewal, change submissions, refusal handling, dossier access and handover; a low upfront fee may transfer substantial later costs.

Minimum file for an evidence-based quote

Send a controlled product list, not simply “one medical device”. Each item below can change either the government-fee base or the service/evidence work.

Intended purpose, clinical claims, user and use environment;
Product type (including IVD or software), risk-class rationale and any Thai FDA determination;
Models, accessories, variants and proposed single/family/system/set grouping;
Import or Thai manufacture, legal applicant and existing establishment-registration status;
Manufacturer sites, quality certificates and authorisation to the Thai applicant;
Existing technical dossier, safety/performance tests, labels, instructions and foreign approvals;
Expected change schedule, target launch, number of applications and requested holder/service scope.

Ask for two columns in every offer: government charges (with assumptions about expert review) and non-government charges (fixed/variable/recurring), plus exclusions, invoicing events and how a rejected or amended filing is charged.

A budget-first sequence that prevents premature spend

Confirm scope and whether the product is a regulated medical device; flag genuine exemption questions instead of assuming an exemption.
Document the Thai risk class, applicant, grouping and likely pathway; seek an official classification/grouping certificate if uncertainty materially affects the budget.
Map existing evidence to the pathway; request a written gap list before ordering tests or translations.
Prepare a base-case and a review/rework reserve, get itemised third-party quotes, then approve filing expenditure.

What this cost page does not replace

For submission milestones, responsibilities and what happens after a dossier is lodged, use the Thai FDA medical-device filing workflow. For a broader engagement and service-deliverables discussion, see medical-device registration services in Thailand. This page is deliberately limited to the budget, variables and reliable quote inputs.

Frequently asked cost questions

Is THB 49,000 always the fee for a Class 2 or 3 import?

No. It is the published component total including THB 38,000 for expert review; whether that component applies requires dossier-specific confirmation. The THB 11,000 subtotal without review is only a conditional calculation.

Does THB 3,100 include setting up a Thai importer?

No. That is the published Class 1 import product-listing total. A new importer establishment is a separate THB 16,100 official line; an existing eligible registrant may already have it.

Can several models be registered for one fee?

Possibly, only if the Thai FDA grouping criteria permit the proposed grouping. A product catalogue alone does not establish the number of applications.

Will CE marking or foreign approval eliminate Thai testing and review costs?

Do not assume so. Prior approvals and reports may support a dossier or a qualifying route, but acceptance, any reliance pathway and missing tests must be assessed for this device.

What must a fixed-price consultant proposal state?

It should identify the applicant and scope, government fee assumptions, dossier and translation work, third-party tests, Thai FDA queries, changes, renewal, recurring holder fees and rejection/re-filing treatment.

Official sources to check before authorising payment

Published schedules and notices can change. Recheck the Thai FDA payment request for the exact application; private-provider prices are not government tariffs.